
Acuity-driven Care — Leveraging Multi-level Monitoring for Complex Needs
It's time that the healthcare industry transitioned from isolated point solutions to an integrated care model that incorporates remote monitoring and virtual care management.
It's time that the healthcare industry transitioned from isolated point solutions to an integrated care model that incorporates remote monitoring and virtual care management.
Sibel Health raised $30 million to accelerate the commercial deployment of its remote patient monitoring platform. The company also announced its seventh FDA clearance, which enables clinicians to use alarms and alerts along with the Sibel’s central platform.
Break down the silos. Take control of your provider data.
This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients.
To overcome challenges and ensure that RPM reaches its full potential, both providers and payers need to implement several key strategies — and technology is a key component to making everything easier on all organizations.
South Florida-based Mount Sinai Medical Center announced a new remote patient monitoring and chronic care management partnership with HealthSnap, a Miami-based virtual care management platform. The partnership is aimed at improving outcomes among the health system’s Medicare population.
This technology can result in reduced readmission rates, increased patient satisfaction, and a consistent flow of post-acute care revenue, especially in rural areas.
At HIMSS24, Heather O'Sullivan, Mass General Brigham's president of healthcare at home, said that the health system wants to move 10% of all its medical patients to the home. She argued that there is "no greater model of care for being patient-centric," and highlighted the care modality's ability to alleviate burnout for some healthcare workers.
HealthSnap closed a $25 million Series B funding round led by Sands Capital. The Miami-based company seeks to help providers better care for a rapidly aging and chronically ill population through its remote patient monitoring platform.
In navigating fiscal uncertainties, it is essential to acknowledge technology as a powerful ally, securing the resilience and long-term sustainability of home care for generations of patients and caregivers to follow.
RPM has ushered in a new era of healthcare. However, navigating the complexities and challenges of this landscape requires a thoughtful QA strategy.
Digital tools like remote monitoring devices, virtual care, and clinical intelligence platforms – all can be leveraged to fill gaps in care in rural hospitals as it relates to care in neonatal intensive care units. In the hands of a collective many, they can be deployed to level the playing field in caring for babies needing special attention and to increase bandwidth and improve adherence to quality guidelines.
Putting all the AI pieces into place effectively requires clarity of what organizations want to accomplish - and for much of healthcare, the Quadruple Aim remains at the very top. Although how to get there will look different, clarity on principles and values that will guide the development of what comes next is paramount to setting us up for years to come.
The next wave of Medtech innovation must deliver truly smart connected care—not only building on our progress in collecting and integrating information about a patient, such as vital signs, diagnostic results and health history—but also using software to prioritize this information, streamline care delivery and provide actionable insights.
A recent webinar sponsored by AVIA Health and Seamless MD examined how health systems use remote patient monitoring beyond the usual chronic condition applications, including surgical prep and recovery, women's health, and more.
Healthcare IT companies raised $1 billion in venture capital in Q2 — down slightly from the $1.3 billion raised in Q1 but up significantly from the $451.3 million raised in Q4 2022. Unsurprisingly, a lot of these investments were made in companies offering generative AI products. Another key trend was increasing cash flow to remote patient monitoring startups, likely caused by expanded reimbursement for these services.